INVO Fertility, Inc. (IVF): Cost of Revenue
$30.6K
Year ended 2025-12-31
$88.8K
Trailing 12 months to 2026-06-30
-52.6%
3-year compound annual growth
-17.3%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.6K | +150.6% | 2026-06-02, From 2025-01-01 |
| 2024-12-31 | $12.2K | n/a | 2026-06-02, From 2024-01-01 |
| No annual figure between 2022-12-31 and 2024-12-31. | |||
| 2022-12-31 | $286.9K | +127.1% | 2023-04-17, From 2022-01-01 |
| 2021-12-31 | $126.3K | +59.8% | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $79.0K | -40.9% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $133.7K | n/a | 2021-03-30, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | 2025-12-31 | $30.6K | +150.6% |
| Encision Inc (ECIA) | 2025-03-31 | $3.04M | -11.8% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $7.43M | +38.4% |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $6.33M | +15.0% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | $3.96M | +66.7% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $5.14M | +14.2% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $4.60M | +7.1% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $6.67M | -6.0% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $2.17M | +19.9% |
Compare IVF, ECIA, XAIR, NSPR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗